MA08.03 Osimertinib vs Platinum-Pemetrexed for T790M-Mutation Positive Advanced NSCLC (AURA3): Plasma ctDNA Analysis

Authors :: Sabina Patel
Te Chun Hsia
Suzanne Jenkins
Sang-We Kim
Janessa Laskin
Vassiliki A. Papadimitrakopoulou
Yong He
Tony Mok
Marcelo Marotti
Rachel Hodge
Angelo Delmonte
Yi-Long Wu
Ji-Youn Han
Suresh S. Ramalingam
Source :: Journal of Thoracic Oncology. 12:S386
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
business.industry
chemistry.chemical_element
03 medical and health sciences
T790M
030104 developmental biology
0302 clinical medicine
Pemetrexed
Oncology
chemistry
030220 oncology & carcinogenesis
Mutation (genetic algorithm)
Cancer research
Medicine
Osimertinib
business
Platinum
medicine.drug

Tools